In this program
we discuss the determination of how specific patient factors can help with the
individualization of antihyperglycemic therapies.
Individualizing Antihyperglycemic Agents in Type 2 Diabetes
CAN-eng
$0
gratuit
Mainpro+
15 mins
Endocrinology
0.25 Credits
Description du cours
Détails du cours
Date d'expiration : 2020-10-10
Métiers: Médecin
Faculté
Peter Lin, MD, CCFP
David C.W. Lau, MD, PhD, FRCPC
Thomas Round, MBBS, BSc, DRCOG, MRCGP
David Strain, MB, ChB, BSc (Hons) MD, FRCP
Elizabeth Rosolowsky, MD, MPH, FAAP, FRCPC
Robyn L. Houlden, MD, FRCPC
John Axler, MD, CCFP, FCFP
Deanna Telner, MD, MEd, CCFP, FCFP
Jeffrey Habert, MD, CCFP, FCFP
Accréditation
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 0.25 Mainpro+ Credit(s).
Cert+ Program ID#: 190712